Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marianne Tveit Haavind"'
Autor:
Nicoline Hoogerbrugge, Cathrine Bjorvatn, Hildegunn Høberg-Vetti, Wenche Listøl, Geir Egil Eide, Marianne Tveit Haavind, Elen Siglen
Publikováno v:
Acta Oncologica, 58, 175-181
Acta Oncologica, 58, 2, pp. 175-181
Acta Oncologica, 58, 2, pp. 175-181
Contains fulltext : 202775.pdf (Publisher’s version ) (Open Access) BACKGROUND: Genetic testing is increasing in patients newly diagnosed with cancer. This study investigated the levels, course and predictors of cancer-related distress, defined as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::285405d06b7d1f072f4a6feab2917b14
https://hdl.handle.net/2066/202775
https://hdl.handle.net/2066/202775
Autor:
Bjørn Ivar Haukanes, Hans Petter Eikesdal, Marianne Tveit Haavind, Wenche Listøl, Bent Fiane, Hildegunn Høberg-Vetti, Nicoline Hoogerbrugge, Tone Rusken, Vidar M. Steen, Kathrine Woie, Turid Aas, Helge Espelid, Cathrine Bjorvatn, Per M. Knappskog
Publikováno v:
European Journal of Human Genetics, 24, 881-8
European Journal of Human Genetics, 24, 6, pp. 881-8
European Journal of Human Genetics
European Journal of Human Genetics, 24, 6, pp. 881-8
European Journal of Human Genetics
Contains fulltext : 172006.pdf (Publisher’s version ) (Open Access) Germline BRCA1/2 testing of breast and ovarian cancer patients is growing rapidly as the result affects both treatment and cancer prevention in patients and relatives. Through the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5084c650b3a3331e1a8d58f6660e0762
https://doi.org/10.1038/ejhg.2015.196
https://doi.org/10.1038/ejhg.2015.196
